V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20213477 | 20129320 | 0 | 86.5 | Palliative (P) | 2018-04-05 | 2018-04-18 | Trial Unspecified | 1 | N | TRIAL | 100951158 |
| 20213478 | 20129321 | 1.85 | 70.7 | Neo-adjuvant (N) | null | 2021-10-20 | EOX | N | N | EOX | 101144329 |
| 20213480 | 20129322 | 1.88 | 105 | Palliative (P) | 2018-05-28 | 2018-05-30 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 101256600 |
| 20213481 | 20129323 | 1.57 | 75.7 | Palliative (P) | 2018-12-17 | 2019-02-01 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 2 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100126598 |
| 20213482 | 20129324 | 1.88 | null | Neo-adjuvant (N) | 2016-06-21 | 2016-07-12 | EOX | N | Y | EOX | 100489576 |
| 20213486 | 20129325 | 1.82 | 78.7 | Palliative (P) | 2020-03-28 | 2020-04-13 | Capecitabine 35days + RT | N | null | CAPECITABINE + RT | 100307024 |
| 20213487 | 20129326 | 1.66 | 104 | Palliative (P) | 2019-10-18 | 2019-11-02 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 101762559 |
| 20213488 | 20129327 | 1.91 | 86 | Palliative (P) | null | 2022-02-26 | Cetuximab + Oxaliplatin + MdG Maint | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101228188 |
| 20213489 | 20129328 | 1.76 | 96 | Curative (C) | 2018-01-19 | 2018-02-02 | IRINOTECAN + MDG + PANITUMUMAB | 01 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101595289 |
| 20213495 | 20129329 | 1.78 | 49.3 | Curative (C) | 2018-02-14 | 2018-03-11 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100443845 |
| 20213496 | 20129330 | 1.75 | 76 | null | 2019-09-03 | 2019-09-03 | Oxaliplatin + Raltitrexed | N | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100657932 |
| 20213498 | 20129331 | 1.59 | 62.5 | null | 2018-04-30 | 2018-05-22 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 2 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101460490 |
| 20213500 | 20129332 | 1.83 | 57.2 | Adjuvant (A) | 2016-10-24 | 2016-10-24 | EOX | N | N | EOX | 101740322 |
| 20213501 | 20129333 | 1.72 | 85 | Curative (C) | 2020-09-21 | 2020-09-21 | Cetuximab + FLUOROURACIL + OXALIPLATIN | N | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100684126 |
| 20213502 | 20129334 | 1.72 | 124 | null | 2019-07-05 | 2019-07-05 | CAPECITABINE + RT | N | null | CAPECITABINE + RT | 101743604 |
| 20213504 | 20129335 | 1.67 | 54.8 | null | 2020-01-20 | 2020-01-20 | Cetuximab + FOLFIRI cycle 2 onwards | 01 | N | CETUXIMAB + IRINOTECAN + MDG | 100773418 |
| 20213505 | 20129336 | 1.78 | 94.6 | Palliative (P) | 2016-06-02 | 2016-06-28 | IRINOTECAN + MDG + PANITUMUMAB | N | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101550248 |
| 20213506 | 20129337 | 0 | 76.7 | null | 2016-08-10 | 2016-10-07 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100865098 |
| 20213507 | 20129338 | 1.85 | 78.5 | Palliative (P) | null | 2020-05-27 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 100168120 |
| 20213508 | 20129339 | 1.67 | 78.4 | Palliative (P) | 2019-04-27 | 2020-01-04 | EOX | 02 | N | EOX | 101614693 |
| 20213509 | 20129340 | 1.58 | 85.7 | Palliative (P) | 2018-03-12 | 2018-03-12 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | N | CETUXIMAB + IRINOTECAN + MDG | 101165402 |
| 20213511 | 20129341 | 1.67 | 63.6 | Curative (C) | null | 2018-04-26 | Oxaliplatin + Raltitrexed | 02 | Y | OXALIPLATIN + RALTITREXED | 101305834 |
| 20213512 | 20129342 | 1.76 | 55.6 | null | null | 2017-01-14 | CAPECITABINE + RT | 2 | null | CAPECITABINE + RT | 100838171 |
| 20213515 | 20129343 | 1.56 | 54 | Palliative (P) | 2018-04-16 | 2018-08-08 | EOX | N | N | TRIAL | 100208130 |
| 20213516 | 20129344 | 1.83 | 69.6 | Curative (C) | 2020-06-12 | 2020-06-27 | IRINOTECAN + MDG + PANITUMUMAB | 2 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100332914 |
| 20213518 | 20129345 | 1.67 | 64.1 | Neo-adjuvant (N) | 2017-03-23 | 2017-04-14 | Sorafenib | 02 | Y | SORAFENIB | 100980451 |
| 20213519 | 20129346 | 1.85 | 100.6 | Palliative (P) | 2018-05-11 | 2018-05-25 | Cetuximab + FLUOROURACIL + OXALIPLATIN | N | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100410799 |
| 20213522 | 20129347 | 1.67 | null | Curative (C) | null | 2018-01-29 | EOX | 99 | Y | CETUXIMAB + IRINOTECAN + MDG | 100724565 |
| 20213523 | 20129348 | 1.46 | 59.4 | null | null | 2019-03-20 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 101584666 |
| 20213524 | 20129349 | 1.75 | null | Palliative (P) | 2019-09-13 | 2019-10-09 | Capecitabine 35days + RT | N | N | CAPECITABINE + RT | 101670821 |
| 20213527 | 20129350 | 1.69 | null | null | 2017-05-25 | 2017-06-01 | EOX | 02 | Y | CAPECITABINE + RT | 100627442 |
| 20213529 | 20129351 | 1.76 | 50.3 | Palliative (P) | 2021-10-07 | 2021-10-24 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101500268 |
| 20213531 | 20129352 | 1.72 | 58.25 | Neo-adjuvant (N) | null | 2018-06-01 | Capecitabine 5days + RT | N | N | CAPECITABINE + RT | 100766596 |
| 20213532 | 20129353 | 1.75 | 61 | Palliative (P) | 2021-07-01 | 2021-07-09 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | N | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101332798 |
| 20213533 | 20129354 | 1.82 | 49.9 | Palliative (P) | 2017-06-29 | 2017-08-01 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100494938 |
| 20213535 | 20129355 | 1.75 | 70 | Palliative (P) | 2018-05-02 | 2018-05-24 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 101394885 |
| 20213536 | 20129356 | 1.81 | 112 | Palliative (P) | null | 2020-12-01 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 01 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101062151 |
| 20213538 | 20129357 | 1.57 | 72 | Palliative (P) | 2019-10-17 | 2019-11-11 | Cetuximab + Oxaliplatin + MdG Load | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101557184 |
| 20213539 | 20129358 | 1.64 | 68.3 | Palliative (P) | 2018-04-09 | 2018-05-01 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + IRINOTECAN + MDG | 100024261 |
| 20213540 | 20129359 | 1.81 | 66.2 | null | 2017-08-06 | 2017-08-10 | Sorafenib | Y | null | SORAFENIB | 100677644 |
| 20213542 | 20129360 | 1.51 | 93 | Palliative (P) | 2019-07-29 | 2019-08-10 | Sorafenib | N | N | SORAFENIB | 101180760 |
| 20213543 | 20129361 | 1.63 | 55 | Palliative (P) | 2017-06-26 | 2017-07-15 | IRINOTECAN + MDG + PANITUMUMAB | 99 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101303199 |
| 20213544 | 20129362 | 1.72 | 78.8 | Palliative (P) | 2014-11-23 | 2019-01-26 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 100590714 |
| 20213545 | 20129363 | 1.76 | 68.4 | Palliative (P) | 2017-12-11 | 2018-01-05 | EOX | N | N | EOX | 101500758 |
| 20213548 | 20129364 | 1.44 | 102.2 | null | 2019-09-16 | 2019-12-06 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | null | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100101557 |
| 20213549 | 20129365 | 1.62 | 56 | Palliative (P) | null | 2017-01-18 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101499719 |
| 20213550 | 20129366 | 0 | 73.2 | Palliative (P) | 2018-06-27 | 2018-07-23 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101321525 |
| 20213551 | 20129367 | 1.9 | 63.2 | Neo-adjuvant (N) | 2018-10-11 | 2018-10-12 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101547047 |
| 20213552 | 20129368 | 1.61 | 79 | Palliative (P) | 2018-06-13 | 2018-06-13 | EOX | N | N | EOX | 101567283 |
| 20213554 | 20129369 | 1.58 | 85.1 | Palliative (P) | 2019-05-28 | 2019-06-13 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | CETUXIMAB + IRINOTECAN + MDG | 101178944 |